Table 2.
Biomarkers | Research courses | Intervention modes (groups) | |||
---|---|---|---|---|---|
No intervention (N = 17) |
Walking (N = 16) |
Vit. C (N = 24) |
Walking + Vit. C (N = 20) |
||
Serum ROS (ng/ml)% | Run 0 | 100.00 ± 34.86 | 85.31 ± 40.30 | 96.28 ± 34.64 | 82.33 ± 35.95 |
Run 1 | 100.00 ± 21.53 | 66.31 ± 28.63## | 84.60 ± 35.65 | 85.01 ± 27.43 | |
Run 2 | 100.00 ± 26.00 | 64.28 ± 28.50## | 88.29 ± 28.68 | 74.28 ± 28.22# | |
Urine 8-OHdG (ng/mgCr)% | Run 0 | 100.00 ± 54.78 | 111.61 ± 47.08 | 110.75 ± 54.76 | 102.01 ± 57.31 |
Run 1 | 100.00 ± 67.62 | 81.32 ± 39.91 | 71.77 ± 30.60** | 56.93 ± 21.08**## | |
Run 2 | 100.00 ± 27.82 | 92.66 ± 33.71 | 102.72 ± 27.99 | 102.55 ± 42.26 | |
Serum TNF-α (pg/ml)% | Run 0 | 100.00 ± 22.84 | 87.08 ± 24.59 | 97.60 ± 22.29 | 91.79 ± 22.82 |
Run 1 | 100.00 ± 18.00 | 84.39 ± 17.36 | 104.22 ± 20.12 | 100.62 ± 22.16 | |
Run 2 | 100.00 ± 27.22 | 93.90 ± 30.24 | 98.79 ± 23.39 | 85.30 ± 23.16 | |
Serum IL-1β (pg/ml)% | Run 0 | 100.00 ± 43.17 | 97.01 ± 41.19 | 142.43 ± 67.97 | 132.91 ± 72.12 |
Run 1 | 100.00 ± 30.60 | 90.01 ± 28.90 | 108.24 ± 28.67* | 101.09 ± 33.65 | |
Run 2 | 100.00 ± 36.34 | 94.86 ± 37.10 | 97.64 ± 30.32** | 84.09 ± 29.95** |
Comparison of research courses: *: compared with Run 0, the difference is significant (p < 0.05);
: compared with Run 0; the difference is very significant (p < 0.01); Comparison of intervention modes:
: compared with no intervention group, the difference is significant (p < 0.05);
: compared with no intervention group, the difference is very significant (p < 0.01).